Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-008210
Filing Date
2023-02-09
Accepted
2023-02-09 21:26:07
Documents
1
Period of Report
2023-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 16641
  Complete submission text file 0001209191-23-008210.txt   18166
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Issuer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TRACON PHARMACEUTICALS, INC. 4350 LA JOLLA VILLAGE DRIVE, SUITE 800 SAN DIEGO CA 92122
Business Address
Adams Bonne J. (Reporting) CIK: 0001965232 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36818 | Film No.: 23608306